Stock chart with arrow pointing down into the ground
(Stock image generated with AI.)

Support from the finance sector couldn’t keep Canada’s main stock index afloat on Thursday, as mounting losses from the mining, industrials, tech and energy segments took their toll on the TSX. However, some gains among healthcare, utilities and telecom stocks capped losses.

Investors on both sides of the border remain on the edge ahead of the U.S. economic data. U.S. stocks could use some new shampoo as it was another split end while Wall Street continues to struggle since September trading begin. The August nonfarm payrolls report is due out Friday, which could play a key role in the Federal Reserve’s interest rate decision later this month.

TSX22,988.28-52.48TSX
TSXV550.28-2.13TSXV
CSE151.40+0.19CSE
DJIA40,755.75-219.22DJIA
NASDAQ17,127.66+43.37NASDAQ
S&P 5005,497.13-22.94S&P 500

The Canadian dollar traded for 74.01 cents U.S. compared with 73.79 cents U.S. on Wednesday.

U.S. crude futures traded $0.01 lower at $69.20 a barrel, but the Brent contract rose $0.01 to $72.71 a barrel.

The price of gold was up US$17.85 to US$2,513.89.

In world markets, the Nikkei was down 390.52 points to 36,657.09, the Hang Seng was down 13.04 points to 17,444.30, the FTSE was down 27.89 points at 8,241.71, but the DAX was up 3.66 points to 18,595.51.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image generated with AI)

More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.